J Lab Med Qual Assur.  2007 Dec;29(2):217-223.

he Performance of the Newly Released Automated Chemistry Analyzer Rx Imola

Affiliations
  • 1Department of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea. kckwon@cnu.ac.kr

Abstract

BACKGROUND: The Rx Imola (Randox, UK) is newly released bench top - fully automated analyzer based on Window XP software with high-throughput (640 tests per hour with ISE) and continuous random access. We evaluated the performance of Rx Imola for the routine chemistry.
METHODS
Repeatability (within-day precision), between-day precision, within-device precision, linearity, recovery rates and correlation were evaluated for 19 items including AST, ALT, ALP, GGT, total bilirubin, calcium, phosphorus, albumin, total protein, BUN, creatinine, glucose, amylase, total cholesterol, triglyceride, HDL, LDH, CK and uric acid. Commercialized quality control materials and patient's sera were used. For correlation study, 747-100 (HITACHI, Japan) and VITROS 950 (Ortho-Clinical Diagnostics, USA) were used as comparative analyzers.
RESULTS
Coefficients of variation (CVs) of all items in repeatability and between-day precision study were below 5%. The linearities were statistically acceptable (R2>0.99) for all items. The recovery rates ranged from 95.7 to 105.3%. The comparison study showed high correlation between Rx Imola and 747-100 or VITROS 950. Correlation coefficients of all items were above 0.99 except HDL and albumin.
CONCLUSIONS
This study showed satisfactory results in precision, linearity, recovery rates and comparison studies of Rx Imola. It was expected to be useful for routine chemistry analysis and back up, because of high performance, easy handling and small size.

Keyword

Rx Imola; Chemistry analyzer

MeSH Terms

Amylases
Bilirubin
Calcium
Chemistry*
Cholesterol
Creatinine
Glucose
Phosphorus
Quality Control
Statistics as Topic
Triglycerides
Uric Acid
Amylases
Bilirubin
Calcium
Cholesterol
Creatinine
Glucose
Phosphorus
Uric Acid
Full Text Links
  • JLMQA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr